Drugs Made In America Acquisition Corp.
DMAADrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
FS-1 | Phase 3 | Tuberculosis, MDR | - | - |
Frequently asked questions
What is in Drugs Made In America Acquisition Corp.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Drugs Made In America Acquisition Corp.'s (DMAA) pipeline across Phase 3. Its lead program is FS-1 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Drugs Made In America Acquisition Corp.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Drugs Made In America Acquisition Corp. (DMAA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track DMAA biotech catalysts?→
Add DMAA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Drugs Made In America Acquisition Corp.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.